Reina Haque to Antineoplastic Agents
This is a "connection" page, showing publications Reina Haque has written about Antineoplastic Agents.
Connection Strength
0.147
-
Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicity. Breast Cancer Res Treat. 2015 Dec; 154(3):609-16.
Score: 0.127
-
A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies. J Clin Epidemiol. 2010 Jan; 63(1):64-74.
Score: 0.020